Insider Trading & Ownership of Caren Deardorf

Location: Cambridge, MA
Summary: The estimated net worth of Caren Deardorf is at least $780,260 dollars as of 13 Jun 2025. Caren Deardorf is the Director of Crinetics Pharmaceuticals, Inc. and owns shares of Crinetics Pharmaceuticals, Inc. (CRNX) stock worth about $543.1K. Caren Deardorf is the Chief Commercial Officer of Magenta Therapeutics, Inc. and owns shares of Dianthus Therapeutics, Inc. /DE/ (DNTH) stock worth about $237.1K.
Signature: /s/ Tobin Schilke, as attorney-in-fact
All Insider Reports: All Insider Reports

Notify me when Caren Deardorf files a new Insider Trading report.

Ownership of Caren Deardorf

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
CRNX	Crinetics Pharmaceuticals, Inc.	Director	$543,116			11 Jun 2025
DNTH	Magenta Therapeutics, Inc.	Chief Commercial Officer	$237,144			30 Nov 2022

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.